I am in the breast imaging business to help to find small breast cancers, but the little ones are tough to identify sometimes.
Yesterday was a busy day in the mammography screening world. One technologist commented, “It looks like the beginning of the July to January mammo push.” I don’t know whether to be excited at the possibility of finding occult breast cancers for more women, or to be a bit scared of the increased opportunities for missing a small breast cancer.
I am in the breast imaging business to help to find small breast cancers. Statistics indicate that treatment of breast cancers smaller than 1 cm gives the woman a 99 percent chance of living a life as if she had never had breast cancer.
So sometimes I wonder what is the point of debating whether a cancer will kill a woman or not. It’s kind of a conundrum. If the parameters used to decide if a cancer is a killing cancer are 100 percent reliable and 100 percent accurate in prediction, then analyzing a cancer for its effect on mortality would be useful. However, the evaluation of cancers for killing potential is not a useable technology at the present time. So, I rely on trying to find cancers smaller than 1 cm to help women to live normal lives in spite of their breast cancer.
The little ones are tough to identify sometimes. They do not have typical appearances. They easily hide amongst the fibroglandular densities, protruding slightly from the contour of the tissue or appearing in a small previously fatty area. Sometimes time tells the story when a small nondescript nodule declares itself with speculated margins and increased density. Using the 20/20 retrospectoscope is disconcerting because the small nondescript density usually can be seen, benignly sitting amongst other similar breast densities.
Radiologists do miss lesions on screening mammograms. Leonard Berlin, MD, in his book “Malpractice Issues in Radiology” quotes studies indicating of miss rates of 25 percent. The itty-bittys just don’t stand out in the crowd.
I’ll just keep trying to find the little ones anyway. Happy beginning of screening mammography season!
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.